Trifluridine/Tipiracil Plus Bevacizumab Improves Survival in Patients With mCRC
Pharma & biotech2018-06-26
14 Views
Patients with metastatic colorectal cancer who are not eligible for chemotherapy or surgical resection may have a new first-line treatment option.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Sponsored Post
Pass Microsoft MTA Certification Exams to Gain Entry into IT Industry
